Birinapant
- Generic Name
- Birinapant
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C42H56F2N8O6
- CAS Number
- 1260251-31-7
- Unique Ingredient Identifier
- 6O4Z07B57R
- Background
Birinapant has been investigated for the treatment of Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML).
- Associated Conditions
- -
- Associated Therapies
- -
Complex IIa formation and ABC transporters determine sensitivity of OSCC to Smac mimetics
Head and neck squamous cell carcinoma: risk factors, molecular alterations, immunology, and peptide vaccines.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath